Data-Driven Policy Research: Who Qualifies and Common Disqualifiers

Trends in Research and Evaluation: Navigating the Evolving Landscape of Cancer Research Funding ## Emerging Priorities in Cancer Research The landscape of cancer research is rapidly evolving, driven by advances in technology, shifting policy priorities, and changing market demands. As a result, researchers and evaluators must stay abreast of the latest trends and priorities in order to remain competitive for funding. One key area of focus is the development of high-risk, high-reward projects that have the potential to drive significant breakthroughs in cancer research. The Banking Institution's Grants to Support Cancer Research Next Generation Leaders program is specifically designed to support early-career investigators pursuing innovative and impactful research. To be successful, applicants must demonstrate a deep understanding of the current research landscape and a clear vision for how their work will advance the field. In particular, the National Science Foundation's (NSF) priorities for cancer research are likely to influence the direction of funding in this area. For instance, the NSF's emphasis on convergence research and the development of novel methodologies and tools is creating new opportunities for researchers who can effectively integrate multiple disciplines and approaches. ## Capacity Requirements for Research and Evaluation To effectively capitalize on emerging trends and priorities in cancer research, researchers and evaluators will need to develop a range of skills and capacities. One key area of focus is the development of advanced data analytics and computational skills, as cancer research increasingly relies on large-scale datasets and complex computational models. Additionally, researchers will need to be able to effectively communicate their findings to a range of stakeholders, including policymakers, clinicians, and patients. The Small Business Innovation Research (SBIR) grant program, which provides funding for small businesses and startups, is one example of an initiative that is driving innovation in cancer research. To be successful, applicants will need to demonstrate a clear understanding of the needs and priorities of these stakeholders, as well as the ability to design and implement effective evaluation strategies. In terms of specific capacity requirements, researchers and evaluators will need to have a strong foundation in cancer biology, as well as expertise in areas such as data science, computational modeling, and statistical analysis. They will also need to be able to effectively collaborate with a range of stakeholders, including clinicians, policymakers, and industry partners. One concrete regulation that applies to this sector is the National Institutes of Health's (NIH) revised Common Rule, which governs the use of human subjects in research. Researchers must ensure that their projects comply with these regulations, which are designed to protect the rights and welfare of research participants. A verifiable delivery challenge unique to this sector is the need to balance the demands of rigorous research with the need for timely and relevant findings. Cancer research is a rapidly evolving field, and researchers must be able to adapt quickly to new developments and advances in order to remain relevant. In terms of operations, research and evaluation projects in cancer research often involve complex workflows and multiple stakeholders. Effective project management is critical to ensuring that projects are delivered on time, within budget, and to the required quality standards. Researchers and evaluators must also be aware of the potential risks and compliance traps associated with cancer research, including issues related to data security, intellectual property, and human subjects protection. To mitigate these risks, researchers must carefully review the eligibility criteria and compliance requirements for funding opportunities, and ensure that their projects are designed and implemented with the necessary safeguards in place. In terms of measurement, researchers and evaluators will need to be able to demonstrate the impact and effectiveness of their work, using metrics such as publication output, citation impact, and patient outcomes. The NSF's emphasis on evaluating the broader impacts of research is one example of the types of metrics that are likely to be used to assess the success of cancer research projects. Required outcomes for funding will likely include the development of new treatments, therapies, or diagnostic tools, as well as the advancement of the field through the publication of research findings and the dissemination of best practices. Reporting requirements will likely include regular progress reports, as well as final reports detailing the outcomes and impacts of the research. Q: What types of projects are eligible for funding under the Banking Institution's Grants to Support Cancer Research Next Generation Leaders program? A: Eligible projects are those that are high-risk, high-reward and have the potential to drive significant breakthroughs in cancer research. Applicants must be early-career investigators and demonstrate a clear vision for how their work will advance the field. Q: How can I ensure that my research project is compliant with NIH regulations regarding human subjects protection? A: To ensure compliance, researchers should carefully review the NIH's revised Common Rule and ensure that their projects are designed and implemented with the necessary safeguards in place. This may involve obtaining Institutional Review Board (IRB) approval and ensuring that all research staff are properly trained in human subjects protection. Q: What metrics will be used to evaluate the success of cancer research projects funded under this program? A: Metrics are likely to include publication output, citation impact, and patient outcomes, as well as the development of new treatments, therapies, or diagnostic tools. Researchers should be prepared to report on these metrics in their progress and final reports.